Skip to main content

Freemont Management S.A.

Position in VRTX — Vertex Pharmaceuticals Inc / Ma

CIK 1609120 VAUD, V8

Position in VRTX

as of Mar 31, 2026 · filed May 6, 2026
Position Value
$2,902,510
-$361,682 QoQ
Shares Held
6,500
-9.7% QoQ
Ownership
0.003%
of shares outstanding
% of Portfolio
0.58%
of 13F equity value
Holder Rank
not a current holder
Holding Since
Dec 2020
21 quarters on record
Voting authority Sole 0% Shared 100% None 0%

Common Shares in VRTX Over Time

Shares Held

Position Value (USD)

Derivatives in VRTX

reported options exposure · as of Sep 30, 2025
CallValue
$2,036,528
CallShares
5,200
PutValue
$0
PutShares
0

Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.

All Filings in VRTX

Export CSV
22 filing rows on record
Report Date Value (USD) Shares
2026-03-31 $2,902,510 6,500
2025-12-31 $3,264,192 7,200
2025-09-30 $939,936 2,400
2025-09-30 $2,036,528 5,200
2025-06-30 $8,904,000 20,000
2025-03-31 $2,811,956 5,800
2024-12-31 $2,577,280 6,400
2024-09-30 $2,976,512 6,400
2024-06-30 $2,999,808 6,400
2024-03-31 $15,758,977 37,700
2023-12-31 $20,100,366 49,400
2023-09-30 $17,178,356 49,400
2023-06-30 $20,305,207 57,700
2023-03-31 $18,179,539 57,700
2022-12-31 $16,662,606 57,700
2022-09-30 $11,726,370 40,500
2022-06-30 $5,861,232 20,800
2022-03-31 $5,741,340 22,000
2021-09-30 $5,804,480 32,000
2021-06-30 $6,452,160 32,000
2021-03-31 $6,876,480 32,000
2020-12-31 $7,562,880 32,000